Xcout Intel
Spore.Bio
Spore.Bio applies machine learning to microbiology testing to help prevent contamination recalls in the food and beverage industry, with headquarters based in Paris, France.
Subscribe to see Spore.Bio’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Spore.Bio at a glance
Spore.Bio is a biotechnology company headquartered in France. Its most recent funding round, Series A, raised $23M in February 2025. Xcout tracks 3 named people at Spore.Bio, including Amine RAJI (CEO).
Spore.Bio leadership
- Amine RAJICEO
- Mohamed TaziCOO
- Maxime MistrettaCTO
Spore.Bio funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $23M | 8 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Spore.Bio competitors
A few of Spore.Bio's closest competitors — see the full list of competitors and alternatives →
LBT Innovations develops automated artificial intelligence technology for microbiology laboratories. Its flagship product, the APAS Independence instrument, automates the imaging, analysis, interpretation, and reporting of culture plates for clinical and pharmaceutical applications.
AbInitio Bio is developing the first foundation models specifically for biomanufacturing. The company is headquartered in San Francisco.
Portal Biotech is a biotechnology company founded by DNA-sequencing veterans that leverages machine learning and nanopore expertise. The firm has built a specialized platform capable of sequencing full-length proteins at the single-molecule level.
Anto Biosciences is a frontier biology AI lab founded in 2025, focusing on developing a foundation model for microbial communities.
Noetik Inc. is an AI-native biotechnology company headquartered in South San Francisco, California, leveraging advanced machine learning methods for biological discovery.
Owkin builds artificial intelligence solutions to automate biopharmaceutical research and development and support clinical research. Its core product, K Pro, is an AI agent that analyzes multimodal patient data to generate insights, inform decision-making, and assist biopharma and healthcare professionals.
Get Spore.Bio's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Spore.Bio in Xcout Intel
- 3 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access